We are live on
!
Find out more
DCM
DAFNA Capital Management Portfolio holdings
AUM
$440M
1-Year Est. Return
109.12%
This Fund
S&P 500
This Quarter
Est. Return
+10.05%
1 Year Est. Return
+109.12%
3 Year Est. Return
+239.59%
5 Year Est. Return
+227.89%
10 Year Est. Return
+3,611.91%
AUM
$206M
AUM Growth
+$19.9M
(+11%)
Cap. Flow
-$6.78M
Cap. Flow
% of AUM
-3.3%
Top 10 Holdings %
Top 10 Hldgs %
45.09%
Holding
85
New
12
Increased
15
Reduced
25
Closed
10
Top Buys
| 1 |
SAGE
Sage Therapeutics
SAGE
|
+$11.1M |
| 2 |
Stereotaxis
STXS
|
+$8.18M |
| 3 |
Akebia Therapeutics
AKBA
|
+$6.64M |
| 4 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
+$4.93M |
| 5 |
LMNX
Luminex Corp
LMNX
|
+$4.14M |
Top Sells
| 1 |
LOXO
Loxo Oncology, Inc
LOXO
|
+$12.2M |
| 2 |
ONC
BeOne Medicines Ltd
ONC
|
+$7.32M |
| 3 |
argenx
ARGX
|
+$2.81M |
| 4 |
Voyager Therapeutics
VYGR
|
+$2.61M |
| 5 |
Ascendis Pharma A/S
ASND
|
+$2.55M |
Sector Composition
| 1 | Healthcare | 86.28% |
| 2 | Financials | 0.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LOXO
1
DELISTED
Loxo Oncology, Inc
LOXO
| $20.9M | 10.19% |
181,537
-114,463
| -39% | -$12.2M |
|
|
SAGE
2
DELISTED
Sage Therapeutics
SAGE
| $15.1M | 7.37% |
94,000
+65,200
| +226% | +$11.1M |
|
|
3
Stereotaxis
STXS
$161M
| $9.1M | 4.43% |
13,680,554
+12,307,692
| +896% | +$8.18M |
|
|
BPMC
4
DELISTED
Blueprint Medicines
BPMC
| $8.13M | 3.96% |
88,691
-12,000
| -12% | -$1.03M |
|
5
AtriCure
ATRC
$1.75B
| $7.99M | 3.88% |
389,145
| – | – |
|
|
NXTM
6
DELISTED
NxStage Medical Inc.
NXTM
| $7.61M | 3.7% |
306,119
+90,000
| +42% | +$2.19M |
|
|
AERI
7
DELISTED
Aerie Pharmaceuticals
AERI
| $7.2M | 3.5% |
132,770
+16,000
| +14% | +$895K |
|
|
8
Akebia Therapeutics
AKBA
$373M
| $5.82M | 2.83% |
610,738
+475,000
| +350% | +$6.64M |
|
9
DexCom
DXCM
$28.1B
| $5.56M | 2.71% |
300,000
-32,000
| -10% | -$473K |
|
|
10
Ascendis Pharma A/S
ASND
$17.6B
| $5.18M | 2.52% |
79,245
-45,394
| -36% | -$2.55M |
|
|
ALDR
11
DELISTED
Alder Biopharmaceuticals
ALDR
| $5.03M | 2.45% |
396,013
+50,000
| +14% | +$723K |
|
|
ARNA
12
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $5.01M | 2.44% |
+126,742
| New | +$4.93M |
|
|
LMNX
13
DELISTED
Luminex Corp
LMNX
| $4.79M | 2.33% |
227,500
+202,500
| +810% | +$4.14M |
|
|
14
argenx
ARGX
$54.1B
| $4.68M | 2.27% |
58,130
-37,266
| -39% | -$2.81M |
|
15
BioCryst Pharmaceuticals
BCRX
$2.39B
| $4.65M | 2.26% |
974,652
-218,576
| -18% | -$1.12M |
|
16
Neurocrine Biosciences
NBIX
$17.3B
| $4.52M | 2.2% |
54,508
| – | – |
|
|
CBAY
17
DELISTED
Cymabay Therapeutics
CBAY
| $4.21M | 2.05% |
323,843
-37,321
| -10% | -$464K |
|
|
IMMU
18
DELISTED
Immunomedics Inc
IMMU
| $4.1M | 2% |
280,900
-23,100
| -8% | -$377K |
|
|
LKFT
19
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.93B
| $3.95M | 1.92% |
39,609
| – | – |
|
|
ZGNX
20
DELISTED
Zogenix, Inc.
ZGNX
| $3.77M | 1.84% |
94,264
-39,883
| -30% | -$1.58M |
|
|
VBIV
21
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $3.49M | 1.7% |
33,267
| – | – |
|
|
ACHN
22
DELISTED
Achillion Pharmaceuticals
ACHN
| $3.22M | 1.57% |
868,272
-80,000
| -8% | -$262K |
|
23
Rigel Pharmaceuticals
RIGL
$762M
| $3.19M | 1.55% |
90,193
-8,155
| -8% | -$326K |
|
24
Insulet
PODD
$11B
| $2.82M | 1.37% |
32,484
| – | – |
|
25
iShares Biotechnology ETF
IBB
$9.24B
| $2.79M | 1.36% |
26,100
| – | – |
|
Similar funds
FGWP
STCG
SCP
CAAM
AWM
HCM
CPW
DWML